CDKN2A and pancreatic neoplasm: In an Italian study, there was a strong correlation between familial pancreatic cancer and the CDKN2A mutation, as 5 out of 16 patients (31%) with FPC carried the mutation (225 patients with PDAC enrolled) [35].